• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Expansion

Emertec et al. invest €5m in Olygose

  • Ellie Pullen
  • 05 January 2015
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Emertec Gestion has taken part in a €5m funding round for Olygose, a French producer of plant-based ingredients for the food and drink industry.

Existing investor Emertec – which invested via its Emertec 4 fund – was joined in the round by new backers CapAgro and Vives Fund, as well as the company's existing angel investors and family office backers.

Vives invested via its Vives II – Louvain Technology Fund vehicle, which held its first close in September 2011 on €43m.

CapAgro led the round and invested via its CapAgro Innovation fund, a venture capital fund that held its first close on €37m in April 2014 and counts Tereos, Sofiprotéol, BPI France and Crédit Agricole as main investors.

Olygose will use the fresh capital to accelerate clinical trials. Its flagship product, AlphaGOS, was recently allowed by the European Food Safety Authority (EFSA) to advertise a health claim related to the reduction of the glycaemic response after a meal.

The company also plans on using the funds to increase its production capacity to several thousand tonnes per year, as well as bolster its international sales teams, particularly in north America and Asia.

The round marks Olygose's second funding round to date, the first having taken place in July 2013.

Company
Founded in 2009 and headquartered in Venette, Olygose is a specialist in natural ingredients derived from plants. The company employs 15 staff.

It extracts and purifies molecules from plants and is currently conducting clinical trials to attempt to demonstrate the benefits of this type of ingredient for certain food, drink and supplement sectors, such as weight management.

People
François Delbaere is the CEO of Olygose. Philippe Durieux is the CEO of the Vives II – Louvain Technology Fund vehicle. CapAgro general manager Jérôme Samson took a seat on Olygose's board of directors, joining existing board member Eric Marty of Emertec.

Advisers
Equity – Brunswick Avocats (Legal); Victor Avocats (Legal); Santarelli (IP due diligence); Adwelsen (Financial due diligence); Artorys (HR due diligence); Naturalpha (R&D due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Expansion
  • France
  • Industrials
  • France

More on Expansion

Blackstone takes minority stake in Groupe Premium
Blackstone takes minority stake in Groupe Premium

Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn

  • Expansion
  • 31 July 2023
e-Attestations aims to triple size with new Keensight backing
e-Attestations aims to triple size with new Keensight backing

Keensight is investing in the risk management platform via its EUR 1bn fifth fund, which closed in 2019

  • Expansion
  • 25 July 2023
The Bolt-Ons Digest - 3 July 2023
The Bolt-Ons Digest - 3 July 2023

Unquoteт€™s selection of the latest add-ons with Palatine's Anthesis, Nordic Capital's Regnology, Waterland's Janssen and more

  • Expansion
  • 03 July 2023
The Bolt-Ons Digest - 26 May 2023
The Bolt-Ons Digest - 26 May 2023

Unquoteт€™s selection of the latest add-ons with H&F's TeamSystem, Nordic Capital's Regnology, 3'i's Dutch Bakery and more

  • Expansion
  • 26 May 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013